Navigation Links
Mylan Launches Generic Version of Plavix® Tablets
Date:5/17/2012

PITTSBURGH, May 17, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clopidogrel Tablets USP, 75 mg and 300 mg. The company was the first to have filed a substantially complete ANDA containing a Paragraph IV certification to the FDA for Clopidogrel Tablets, 300 mg, and was awarded 180 days of marketing exclusivity for this strength. This product is the generic version of Sanofi-Aventis' Plavix® and is indicated for acute coronary syndrome and for patients with a recent history of myocardial infarction, stroke or established peripheral arterial disease.[1]

Mylan Pharmaceuticals will provide customers with the 75 mg strength of this product in bottle form, and Mylan Institutional, which serves the institutional pharmaceutical market, will supply the 300 mg strength exclusively in unit dose packs of 30. This business also will supply Clopidogrel Tablets, 75 mg, in unit dose packs of 100. Mylan is shipping all product presentations immediately.

Plavix Tablets, 75 mg and 300 mg, had U.S. sales of approximately $6.7 billion for the 12 months ending March 31, 2012, according to IMS Health.

Currently, Mylan has 173 ANDAs pending FDA approval representing $98.2 billion in annual sales, according to IMS Health. Thirty-nine of these pending ANDAs are potential first-to-file opportunities, representing $25.5 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com 


[1] Clopidogrel has been shown to be less effective in people who are known as "CYP2C19 poor metabolizers."  A blood test is used to determine if a person is a poor metabolizer. Clopidogrel is not indicated in those who are allergic to it or have active bleeding. Clopidogrel can increase the risk of bleeding and should be discontinued five days before surgery. Premature discontinuations can increase the risk for cardiovascular events and in patients who have had a recent transient ischemic attack or stroke. The combination of clopidogrel and aspirin can increase major bleeding. Fatal thrombotic thrombocytopenic purpura has also been reported.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Launches Generic Lipitor® in Five European Countries
2. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
3. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
4. Mylan Launches Generic Version of Zyprexa® Tablets
5. Mylan Launches First Generic Version of Lescol® Capsules
6. Mylan Schedules First Quarter 2012 Financial Results Conference Call and Live Webcast
7. Mylan One of First to Launch Generic Version of Boniva®
8. Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
9. Mylan Continues to Pursue Damages and Injunction Against Sunovions Brovana® in Ongoing Litigation
10. Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA
11. Mylan Secures an Additional $300 Million of Committed Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , December 8, 2016 ... Excipients Market by Product (Actual Sugars, Sugar Alcohols, ... & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) ... the market has witnessed healthy growth during the ... a CAGR of 4.3% between 2016 and 2021 ...
(Date:12/8/2016)... , December 8, 2016 According to a ... Pulse, BP, Sleep, Fetal), Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), ... published by MarketsandMarkets, the global market, in terms of value, is projected ... at a CAGR of 18.0% during the forecast period. ... ...
(Date:12/8/2016)... ANGELES , Dec. 8, 2016  Hanson ... manufacturing of dissolution testing and diffusion testing instruments ... been acquired by Teledyne Instruments, Inc. ("Teledyne"). The ... long-proven line of precision testing instruments, as well ... accelerating development of new products and services. ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... planning services from offices headquartered in Little Rock, has initiated a charity drive ... to the National Foundation to End Senior Hunger, Arkansas ranks first in senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family ... in and around the Hancock County area, is announcing the launch of a charity ... , The Hancock County Food Pantry has worked for more than 30 years to ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA and ... comprehensive mental health systems reform legislation in more than fifty years. We applaud ... commitment of our elected officials to improving mental health services and supports in ...
Breaking Medicine News(10 mins):